Page last updated: 2024-08-23

colforsin and rpl 554

colforsin has been researched along with rpl 554 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Hanrahan, JW; Luo, Y; Thomas, DY; Turner, MJ1

Other Studies

1 other study(ies) available for colforsin and rpl 554

ArticleYear
The dual phosphodiesterase 3/4 inhibitor RPL554 stimulates rare class III and IV CFTR mutants.
    American journal of physiology. Lung cellular and molecular physiology, 2020, 05-01, Volume: 318, Issue:5

    Topics: Aminopyridines; Animals; Benzodioxoles; Bronchi; Cell Line; Colforsin; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclic Nucleotide Phosphodiesterases, Type 4; Cystic Fibrosis Transmembrane Conductance Regulator; Humans; Isoquinolines; Mutation; Phosphodiesterase 3 Inhibitors; Phosphodiesterase 4 Inhibitors; Primary Cell Culture; Pyrimidinones; Rats; Rats, Inbred F344; Thyroid Epithelial Cells; Transgenes

2020